nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Bexarotene—hematologic cancer	0.0383	0.0829	CbGbCtD
Dantrolene—CYP3A4—Busulfan—hematologic cancer	0.0356	0.0771	CbGbCtD
Dantrolene—CYP3A4—Lomustine—hematologic cancer	0.0356	0.0771	CbGbCtD
Dantrolene—CYP3A4—Thiotepa—hematologic cancer	0.0318	0.0687	CbGbCtD
Dantrolene—CYP3A4—Methoxsalen—hematologic cancer	0.0247	0.0534	CbGbCtD
Dantrolene—CYP3A4—Bortezomib—hematologic cancer	0.0235	0.0508	CbGbCtD
Dantrolene—CYP3A4—Daunorubicin—hematologic cancer	0.0225	0.0486	CbGbCtD
Dantrolene—CYP3A4—Cytarabine—hematologic cancer	0.0198	0.0429	CbGbCtD
Dantrolene—CYP3A4—Teniposide—hematologic cancer	0.0195	0.0422	CbGbCtD
Dantrolene—CYP3A4—Ifosfamide—hematologic cancer	0.018	0.039	CbGbCtD
Dantrolene—CYP3A4—Imatinib—hematologic cancer	0.0172	0.0372	CbGbCtD
Dantrolene—CYP3A4—Ruxolitinib—hematologic cancer	0.0162	0.0351	CbGbCtD
Dantrolene—CYP3A4—Nilotinib—hematologic cancer	0.0156	0.0338	CbGbCtD
Dantrolene—CYP3A4—Vinorelbine—hematologic cancer	0.0155	0.0335	CbGbCtD
Dantrolene—CYP3A4—Triamcinolone—hematologic cancer	0.0142	0.0307	CbGbCtD
Dantrolene—CYP3A4—Dasatinib—hematologic cancer	0.0138	0.0299	CbGbCtD
Dantrolene—CYP3A4—Mitoxantrone—hematologic cancer	0.0137	0.0295	CbGbCtD
Dantrolene—CYP3A4—Betamethasone—hematologic cancer	0.0122	0.0263	CbGbCtD
Dantrolene—CYP3A4—Prednisolone—hematologic cancer	0.012	0.026	CbGbCtD
Dantrolene—RYR3—hematopoietic system—hematologic cancer	0.0116	0.259	CbGeAlD
Dantrolene—CYP3A4—Prednisone—hematologic cancer	0.0113	0.0245	CbGbCtD
Dantrolene—CYP3A4—Irinotecan—hematologic cancer	0.0107	0.0232	CbGbCtD
Dantrolene—CYP3A4—Vinblastine—hematologic cancer	0.00956	0.0207	CbGbCtD
Dantrolene—CYP3A4—Vincristine—hematologic cancer	0.0094	0.0203	CbGbCtD
Dantrolene—CYP3A4—Etoposide—hematologic cancer	0.00861	0.0186	CbGbCtD
Dantrolene—RYR3—blood—hematologic cancer	0.00771	0.171	CbGeAlD
Dantrolene—CYP3A4—Dexamethasone—hematologic cancer	0.00708	0.0153	CbGbCtD
Dantrolene—RYR3—lung—hematologic cancer	0.00676	0.15	CbGeAlD
Dantrolene—RYR3—testis—hematologic cancer	0.00637	0.142	CbGeAlD
Dantrolene—CYP3A4—Doxorubicin—hematologic cancer	0.00587	0.0127	CbGbCtD
Dantrolene—RYR3—Alzheimers Disease—CAPN2—hematologic cancer	0.00575	0.0458	CbGpPWpGaD
Dantrolene—RYR1—blood—hematologic cancer	0.00553	0.123	CbGeAlD
Dantrolene—RYR1—testis—hematologic cancer	0.00457	0.102	CbGeAlD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ANXA6—hematologic cancer	0.00457	0.0364	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ANXA6—hematologic cancer	0.00337	0.0268	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJB3—hematologic cancer	0.00317	0.0252	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—SNCA—hematologic cancer	0.00296	0.0236	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—FXYD6—hematologic cancer	0.00275	0.0219	CbGpPWpGaD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—hematologic cancer	0.00271	0.0215	CbGpPWpGaD
Dantrolene—RYR3—Stimuli-sensing channels—SGK1—hematologic cancer	0.00261	0.0207	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MME—hematologic cancer	0.00241	0.0192	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJB3—hematologic cancer	0.00233	0.0186	CbGpPWpGaD
Dantrolene—Nitrofurantoin—ABCG2—hematologic cancer	0.00233	0.933	CrCbGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJB6—hematologic cancer	0.00223	0.0178	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ATP1B1—hematologic cancer	0.0021	0.0167	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJB2—hematologic cancer	0.0021	0.0167	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—FXYD6—hematologic cancer	0.00203	0.0162	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ATP1B1—hematologic cancer	0.00196	0.0156	CbGpPWpGaD
Dantrolene—RYR1—Stimuli-sensing channels—SGK1—hematologic cancer	0.00192	0.0153	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP7—hematologic cancer	0.00173	0.0137	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—SGK1—hematologic cancer	0.0017	0.0135	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ATP4A—hematologic cancer	0.0017	0.0135	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJB6—hematologic cancer	0.00164	0.0131	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ATP1B1—hematologic cancer	0.00155	0.0123	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJB2—hematologic cancer	0.00155	0.0123	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CYCS—hematologic cancer	0.00146	0.0116	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—RGS2—hematologic cancer	0.00145	0.0116	CbGpPWpGaD
Dantrolene—CYP3A4—hematopoietic system—hematologic cancer	0.00145	0.0322	CbGeAlD
Dantrolene—RYR1—Ion channel transport—ATP1B1—hematologic cancer	0.00145	0.0115	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—RGS2—hematologic cancer	0.00141	0.0112	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—GSTO1—hematologic cancer	0.00139	0.0111	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—LPAR1—hematologic cancer	0.00135	0.0107	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.00132	0.0105	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ATP4A—hematologic cancer	0.00125	0.00998	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—SGK1—hematologic cancer	0.00125	0.00998	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PDE4B—hematologic cancer	0.00124	0.00988	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADCY7—hematologic cancer	0.0012	0.00959	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ADCY7—hematologic cancer	0.00117	0.00929	CbGpPWpGaD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	0.00108	0.00857	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—RGS2—hematologic cancer	0.00107	0.00853	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CAMK2D—hematologic cancer	0.00107	0.00853	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—FAS—hematologic cancer	0.00106	0.00842	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—RGS2—hematologic cancer	0.00104	0.00826	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CAMK2D—hematologic cancer	0.00104	0.00826	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00103	0.0082	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GSTO1—hematologic cancer	0.00103	0.00817	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCZ—hematologic cancer	0.00101	0.008	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—LPAR1—hematologic cancer	0.000994	0.00791	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CALR—hematologic cancer	0.000987	0.00786	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCZ—hematologic cancer	0.000974	0.00775	CbGpPWpGaD
Dantrolene—CYP3A4—blood—hematologic cancer	0.000961	0.0214	CbGeAlD
Dantrolene—RYR3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000958	0.00763	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PDE4B—hematologic cancer	0.000915	0.00728	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—BAD—hematologic cancer	0.000904	0.0072	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADCY7—hematologic cancer	0.000888	0.00707	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ADCY7—hematologic cancer	0.00086	0.00685	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP8—hematologic cancer	0.000815	0.00649	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CAMK2D—hematologic cancer	0.00079	0.00629	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000781	0.00622	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CAMK2D—hematologic cancer	0.000765	0.00609	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000762	0.00606	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00076	0.00605	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCZ—hematologic cancer	0.000741	0.0059	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CALR—hematologic cancer	0.000728	0.0058	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000726	0.00578	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCZ—hematologic cancer	0.000718	0.00572	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000716	0.0057	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000706	0.00562	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000683	0.00543	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCG—hematologic cancer	0.000677	0.00539	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCG—hematologic cancer	0.000656	0.00523	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000647	0.00515	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—IL1B—hematologic cancer	0.000618	0.00492	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—hematologic cancer	0.000617	0.00491	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000592	0.00471	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000592	0.00471	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000592	0.00471	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000576	0.00458	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000535	0.00426	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000533	0.00424	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000503	0.00401	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCG—hematologic cancer	0.000499	0.00398	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MAPK3—hematologic cancer	0.000495	0.00394	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—FOS—hematologic cancer	0.000487	0.00388	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CREB1—hematologic cancer	0.000486	0.00387	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCG—hematologic cancer	0.000484	0.00385	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000477	0.0038	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000468	0.00372	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	0.000458	0.00364	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—hematologic cancer	0.000449	0.00357	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	0.000449	0.00357	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000436	0.00347	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000436	0.00347	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000436	0.00347	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000428	0.00341	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	0.000419	0.00333	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000417	0.00332	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000404	0.00321	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	0.000397	0.00316	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TP53—hematologic cancer	0.000396	0.00315	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000393	0.00313	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000392	0.00312	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000389	0.0031	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000388	0.00309	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000381	0.00304	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000374	0.00298	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—hematologic cancer	0.000361	0.00287	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—FOS—hematologic cancer	0.000359	0.00286	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CREB1—hematologic cancer	0.000358	0.00285	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—JUN—hematologic cancer	0.00035	0.00278	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000345	0.00275	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00034	0.00271	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000337	0.00268	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000315	0.00251	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000303	0.00241	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000298	0.00237	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000289	0.0023	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000287	0.00228	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000285	0.00227	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000281	0.00224	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—hematologic cancer	0.000266	0.00212	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—hematologic cancer	0.000258	0.00205	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	0.000257	0.00204	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000251	0.002	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000251	0.00199	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000239	0.00191	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000238	0.00189	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000236	0.00188	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000212	0.00169	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—hematologic cancer	0.000211	0.00168	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00021	0.00167	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	0.000197	0.00157	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000184	0.00147	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000175	0.0014	CbGpPWpGaD
Dantrolene—Nitrazepam—ABCB1—hematologic cancer	0.000168	0.0671	CrCbGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000159	0.00127	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—hematologic cancer	0.000156	0.00124	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000152	0.00121	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000149	0.00119	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000128	0.00102	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000122	0.00097	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000121	0.000963	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000117	0.000934	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—hematologic cancer	0.00011	0.000874	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	0.000102	0.000809	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	0.0001	0.000797	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	6.54e-05	0.000521	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	6.46e-05	0.000514	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	6.15e-05	0.00049	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	6.07e-05	0.000483	CbGpPWpGaD
Dantrolene—Rash—Mitoxantrone—hematologic cancer	5.85e-05	0.00016	CcSEcCtD
Dantrolene—Rash—Irinotecan—hematologic cancer	5.85e-05	0.00016	CcSEcCtD
Dantrolene—Dermatitis—Irinotecan—hematologic cancer	5.85e-05	0.00016	CcSEcCtD
Dantrolene—Dermatitis—Mitoxantrone—hematologic cancer	5.85e-05	0.00016	CcSEcCtD
Dantrolene—Chills—Methotrexate—hematologic cancer	5.84e-05	0.00016	CcSEcCtD
Dantrolene—Headache—Mitoxantrone—hematologic cancer	5.81e-05	0.000159	CcSEcCtD
Dantrolene—Headache—Irinotecan—hematologic cancer	5.81e-05	0.000159	CcSEcCtD
Dantrolene—Nausea—Ifosfamide—hematologic cancer	5.81e-05	0.000159	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.79e-05	0.000159	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.79e-05	0.000159	CcSEcCtD
Dantrolene—Myalgia—Prednisone—hematologic cancer	5.77e-05	0.000158	CcSEcCtD
Dantrolene—Feeling abnormal—Triamcinolone—hematologic cancer	5.77e-05	0.000158	CcSEcCtD
Dantrolene—Diarrhoea—Cisplatin—hematologic cancer	5.76e-05	0.000158	CcSEcCtD
Dantrolene—Vomiting—Gemcitabine—hematologic cancer	5.75e-05	0.000158	CcSEcCtD
Dantrolene—Insomnia—Dexamethasone—hematologic cancer	5.75e-05	0.000158	CcSEcCtD
Dantrolene—Insomnia—Betamethasone—hematologic cancer	5.75e-05	0.000158	CcSEcCtD
Dantrolene—Discomfort—Prednisone—hematologic cancer	5.7e-05	0.000156	CcSEcCtD
Dantrolene—Rash—Gemcitabine—hematologic cancer	5.7e-05	0.000156	CcSEcCtD
Dantrolene—Dermatitis—Gemcitabine—hematologic cancer	5.69e-05	0.000156	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—hematologic cancer	5.69e-05	0.000156	CcSEcCtD
Dantrolene—Erythema—Methotrexate—hematologic cancer	5.67e-05	0.000155	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—hematologic cancer	5.66e-05	0.000155	CcSEcCtD
Dantrolene—Headache—Gemcitabine—hematologic cancer	5.66e-05	0.000155	CcSEcCtD
Dantrolene—Nausea—Vincristine—hematologic cancer	5.66e-05	0.000155	CcSEcCtD
Dantrolene—Flushing—Epirubicin—hematologic cancer	5.65e-05	0.000155	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—hematologic cancer	5.64e-05	0.000155	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—hematologic cancer	5.64e-05	0.000155	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisolone—hematologic cancer	5.61e-05	0.000154	CcSEcCtD
Dantrolene—Dyspepsia—Betamethasone—hematologic cancer	5.59e-05	0.000153	CcSEcCtD
Dantrolene—Dyspepsia—Dexamethasone—hematologic cancer	5.59e-05	0.000153	CcSEcCtD
Dantrolene—Urticaria—Triamcinolone—hematologic cancer	5.56e-05	0.000153	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—hematologic cancer	5.55e-05	0.000152	CcSEcCtD
Dantrolene—Asthenia—Etoposide—hematologic cancer	5.54e-05	0.000152	CcSEcCtD
Dantrolene—Body temperature increased—Triamcinolone—hematologic cancer	5.53e-05	0.000152	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—hematologic cancer	5.53e-05	0.000152	CcSEcCtD
Dantrolene—Decreased appetite—Dexamethasone—hematologic cancer	5.52e-05	0.000151	CcSEcCtD
Dantrolene—Decreased appetite—Betamethasone—hematologic cancer	5.52e-05	0.000151	CcSEcCtD
Dantrolene—Nausea—Mitoxantrone—hematologic cancer	5.51e-05	0.000151	CcSEcCtD
Dantrolene—Nausea—Irinotecan—hematologic cancer	5.51e-05	0.000151	CcSEcCtD
Dantrolene—Back pain—Methotrexate—hematologic cancer	5.48e-05	0.00015	CcSEcCtD
Dantrolene—Fatigue—Betamethasone—hematologic cancer	5.48e-05	0.00015	CcSEcCtD
Dantrolene—Fatigue—Dexamethasone—hematologic cancer	5.48e-05	0.00015	CcSEcCtD
Dantrolene—Chills—Epirubicin—hematologic cancer	5.46e-05	0.00015	CcSEcCtD
Dantrolene—Pruritus—Etoposide—hematologic cancer	5.46e-05	0.00015	CcSEcCtD
Dantrolene—Pain—Dexamethasone—hematologic cancer	5.43e-05	0.000149	CcSEcCtD
Dantrolene—Pain—Betamethasone—hematologic cancer	5.43e-05	0.000149	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—hematologic cancer	5.43e-05	0.000149	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	5.43e-05	0.000432	CbGpPWpGaD
Dantrolene—Tachycardia—Prednisone—hematologic cancer	5.4e-05	0.000148	CcSEcCtD
Dantrolene—Nausea—Gemcitabine—hematologic cancer	5.37e-05	0.000147	CcSEcCtD
Dantrolene—Vomiting—Cisplatin—hematologic cancer	5.36e-05	0.000147	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—hematologic cancer	5.35e-05	0.000147	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—hematologic cancer	5.34e-05	0.000146	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—MTR—hematologic cancer	5.34e-05	0.000425	CbGpPWpGaD
Dantrolene—Rash—Cisplatin—hematologic cancer	5.31e-05	0.000146	CcSEcCtD
Dantrolene—Dermatitis—Cisplatin—hematologic cancer	5.31e-05	0.000146	CcSEcCtD
Dantrolene—Erythema—Epirubicin—hematologic cancer	5.3e-05	0.000145	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—hematologic cancer	5.28e-05	0.000145	CcSEcCtD
Dantrolene—Anorexia—Prednisone—hematologic cancer	5.27e-05	0.000145	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—hematologic cancer	5.26e-05	0.000144	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—hematologic cancer	5.24e-05	0.000144	CcSEcCtD
Dantrolene—Feeling abnormal—Betamethasone—hematologic cancer	5.23e-05	0.000144	CcSEcCtD
Dantrolene—Feeling abnormal—Dexamethasone—hematologic cancer	5.23e-05	0.000144	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—hematologic cancer	5.23e-05	0.000143	CcSEcCtD
Dantrolene—Tension—Epirubicin—hematologic cancer	5.2e-05	0.000143	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.19e-05	0.000142	CcSEcCtD
Dantrolene—Gastrointestinal pain—Betamethasone—hematologic cancer	5.19e-05	0.000142	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—hematologic cancer	5.19e-05	0.000142	CcSEcCtD
Dantrolene—Hypersensitivity—Triamcinolone—hematologic cancer	5.16e-05	0.000141	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—hematologic cancer	5.15e-05	0.000141	CcSEcCtD
Dantrolene—Back pain—Epirubicin—hematologic cancer	5.13e-05	0.000141	CcSEcCtD
Dantrolene—Malaise—Methotrexate—hematologic cancer	5.11e-05	0.00014	CcSEcCtD
Dantrolene—Dizziness—Etoposide—hematologic cancer	5.1e-05	0.00014	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	5.07e-05	0.000404	CbGpPWpGaD
Dantrolene—Leukopenia—Methotrexate—hematologic cancer	5.07e-05	0.000139	CcSEcCtD
Dantrolene—Chills—Doxorubicin—hematologic cancer	5.06e-05	0.000139	CcSEcCtD
Dantrolene—Urticaria—Dexamethasone—hematologic cancer	5.05e-05	0.000138	CcSEcCtD
Dantrolene—Urticaria—Betamethasone—hematologic cancer	5.05e-05	0.000138	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.04e-05	0.000138	CcSEcCtD
Dantrolene—Dizziness—Prednisolone—hematologic cancer	5.03e-05	0.000138	CcSEcCtD
Dantrolene—Asthenia—Triamcinolone—hematologic cancer	5.02e-05	0.000138	CcSEcCtD
Dantrolene—Abdominal pain—Dexamethasone—hematologic cancer	5.02e-05	0.000138	CcSEcCtD
Dantrolene—Body temperature increased—Betamethasone—hematologic cancer	5.02e-05	0.000138	CcSEcCtD
Dantrolene—Body temperature increased—Dexamethasone—hematologic cancer	5.02e-05	0.000138	CcSEcCtD
Dantrolene—Abdominal pain—Betamethasone—hematologic cancer	5.02e-05	0.000138	CcSEcCtD
Dantrolene—Nausea—Cisplatin—hematologic cancer	5e-05	0.000137	CcSEcCtD
Dantrolene—Insomnia—Prednisone—hematologic cancer	5e-05	0.000137	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—hematologic cancer	5e-05	0.000137	CcSEcCtD
Dantrolene—Pruritus—Triamcinolone—hematologic cancer	4.95e-05	0.000136	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—hematologic cancer	4.92e-05	0.000135	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—hematologic cancer	4.91e-05	0.000135	CcSEcCtD
Dantrolene—Vomiting—Etoposide—hematologic cancer	4.91e-05	0.000135	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—hematologic cancer	4.91e-05	0.000135	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—hematologic cancer	4.9e-05	0.000134	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—hematologic cancer	4.87e-05	0.000134	CcSEcCtD
Dantrolene—Rash—Etoposide—hematologic cancer	4.87e-05	0.000133	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—hematologic cancer	4.86e-05	0.000133	CcSEcCtD
Dantrolene—Headache—Etoposide—hematologic cancer	4.84e-05	0.000133	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—hematologic cancer	4.82e-05	0.000132	CcSEcCtD
Dantrolene—Tension—Doxorubicin—hematologic cancer	4.81e-05	0.000132	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—hematologic cancer	4.81e-05	0.000132	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—hematologic cancer	4.8e-05	0.000132	CcSEcCtD
Dantrolene—Rash—Prednisolone—hematologic cancer	4.8e-05	0.000132	CcSEcCtD
Dantrolene—Dermatitis—Prednisolone—hematologic cancer	4.8e-05	0.000132	CcSEcCtD
Dantrolene—Malaise—Epirubicin—hematologic cancer	4.78e-05	0.000131	CcSEcCtD
Dantrolene—Fatigue—Prednisone—hematologic cancer	4.77e-05	0.000131	CcSEcCtD
Dantrolene—Headache—Prednisolone—hematologic cancer	4.77e-05	0.000131	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—hematologic cancer	4.77e-05	0.000131	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—hematologic cancer	4.76e-05	0.000131	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—hematologic cancer	4.75e-05	0.00013	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—hematologic cancer	4.74e-05	0.00013	CcSEcCtD
Dantrolene—Constipation—Prednisone—hematologic cancer	4.73e-05	0.00013	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—hematologic cancer	4.66e-05	0.000128	CcSEcCtD
Dantrolene—Dizziness—Triamcinolone—hematologic cancer	4.63e-05	0.000127	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—hematologic cancer	4.62e-05	0.000127	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—hematologic cancer	4.62e-05	0.000127	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—hematologic cancer	4.59e-05	0.000126	CcSEcCtD
Dantrolene—Nausea—Etoposide—hematologic cancer	4.58e-05	0.000126	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—hematologic cancer	4.58e-05	0.000126	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisone—hematologic cancer	4.56e-05	0.000125	CcSEcCtD
Dantrolene—Asthenia—Dexamethasone—hematologic cancer	4.56e-05	0.000125	CcSEcCtD
Dantrolene—Asthenia—Betamethasone—hematologic cancer	4.56e-05	0.000125	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—hematologic cancer	4.55e-05	0.000125	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—hematologic cancer	4.53e-05	0.000124	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—hematologic cancer	4.53e-05	0.000124	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—hematologic cancer	4.52e-05	0.000124	CcSEcCtD
Dantrolene—Nausea—Prednisolone—hematologic cancer	4.52e-05	0.000124	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—hematologic cancer	4.51e-05	0.000124	CcSEcCtD
Dantrolene—Pruritus—Dexamethasone—hematologic cancer	4.49e-05	0.000123	CcSEcCtD
Dantrolene—Pruritus—Betamethasone—hematologic cancer	4.49e-05	0.000123	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—hematologic cancer	4.47e-05	0.000123	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—hematologic cancer	4.46e-05	0.000122	CcSEcCtD
Dantrolene—Vomiting—Triamcinolone—hematologic cancer	4.45e-05	0.000122	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—hematologic cancer	4.42e-05	0.000121	CcSEcCtD
Dantrolene—Rash—Triamcinolone—hematologic cancer	4.41e-05	0.000121	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—hematologic cancer	4.41e-05	0.000121	CcSEcCtD
Dantrolene—Dermatitis—Triamcinolone—hematologic cancer	4.41e-05	0.000121	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—hematologic cancer	4.41e-05	0.000121	CcSEcCtD
Dantrolene—Urticaria—Prednisone—hematologic cancer	4.39e-05	0.000121	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—hematologic cancer	4.39e-05	0.00012	CcSEcCtD
Dantrolene—Headache—Triamcinolone—hematologic cancer	4.39e-05	0.00012	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—hematologic cancer	4.37e-05	0.00012	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—hematologic cancer	4.37e-05	0.00012	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—hematologic cancer	4.36e-05	0.00012	CcSEcCtD
Dantrolene—Diarrhoea—Dexamethasone—hematologic cancer	4.35e-05	0.000119	CcSEcCtD
Dantrolene—Diarrhoea—Betamethasone—hematologic cancer	4.35e-05	0.000119	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—hematologic cancer	4.33e-05	0.000119	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—hematologic cancer	4.25e-05	0.000117	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—hematologic cancer	4.24e-05	0.000116	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—hematologic cancer	4.24e-05	0.000116	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—hematologic cancer	4.22e-05	0.000116	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.21e-05	0.000116	CcSEcCtD
Dantrolene—Dizziness—Dexamethasone—hematologic cancer	4.2e-05	0.000115	CcSEcCtD
Dantrolene—Dizziness—Betamethasone—hematologic cancer	4.2e-05	0.000115	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—hematologic cancer	4.18e-05	0.000115	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—hematologic cancer	4.18e-05	0.000115	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—hematologic cancer	4.18e-05	0.000115	CcSEcCtD
Dantrolene—Nausea—Triamcinolone—hematologic cancer	4.16e-05	0.000114	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—hematologic cancer	4.13e-05	0.000113	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—hematologic cancer	4.12e-05	0.000113	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—hematologic cancer	4.11e-05	0.000113	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—hematologic cancer	4.08e-05	0.000112	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—hematologic cancer	4.08e-05	0.000112	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—hematologic cancer	4.07e-05	0.000112	CcSEcCtD
Dantrolene—Vomiting—Betamethasone—hematologic cancer	4.04e-05	0.000111	CcSEcCtD
Dantrolene—Vomiting—Dexamethasone—hematologic cancer	4.04e-05	0.000111	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—hematologic cancer	4.04e-05	0.000111	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—hematologic cancer	4.02e-05	0.00011	CcSEcCtD
Dantrolene—Rash—Betamethasone—hematologic cancer	4.01e-05	0.00011	CcSEcCtD
Dantrolene—Rash—Dexamethasone—hematologic cancer	4.01e-05	0.00011	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—hematologic cancer	4e-05	0.00011	CcSEcCtD
Dantrolene—Dermatitis—Dexamethasone—hematologic cancer	4e-05	0.00011	CcSEcCtD
Dantrolene—Dermatitis—Betamethasone—hematologic cancer	4e-05	0.00011	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—hematologic cancer	3.99e-05	0.000109	CcSEcCtD
Dantrolene—Headache—Betamethasone—hematologic cancer	3.98e-05	0.000109	CcSEcCtD
Dantrolene—Headache—Dexamethasone—hematologic cancer	3.98e-05	0.000109	CcSEcCtD
Dantrolene—Asthenia—Prednisone—hematologic cancer	3.97e-05	0.000109	CcSEcCtD
Dantrolene—Pain—Methotrexate—hematologic cancer	3.95e-05	0.000108	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.94e-05	0.000108	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—hematologic cancer	3.92e-05	0.000108	CcSEcCtD
Dantrolene—Pruritus—Prednisone—hematologic cancer	3.91e-05	0.000107	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—hematologic cancer	3.91e-05	0.000107	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—hematologic cancer	3.91e-05	0.000107	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—hematologic cancer	3.87e-05	0.000106	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—hematologic cancer	3.85e-05	0.000106	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—hematologic cancer	3.82e-05	0.000105	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—hematologic cancer	3.81e-05	0.000105	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—hematologic cancer	3.81e-05	0.000104	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—hematologic cancer	3.79e-05	0.000104	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—hematologic cancer	3.78e-05	0.000104	CcSEcCtD
Dantrolene—Nausea—Dexamethasone—hematologic cancer	3.77e-05	0.000104	CcSEcCtD
Dantrolene—Nausea—Betamethasone—hematologic cancer	3.77e-05	0.000104	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—hematologic cancer	3.76e-05	0.000103	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—hematologic cancer	3.73e-05	0.000102	CcSEcCtD
Dantrolene—Pain—Epirubicin—hematologic cancer	3.7e-05	0.000101	CcSEcCtD
Dantrolene—Constipation—Epirubicin—hematologic cancer	3.7e-05	0.000101	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—hematologic cancer	3.67e-05	0.000101	CcSEcCtD
Dantrolene—Dizziness—Prednisone—hematologic cancer	3.66e-05	0.0001	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—hematologic cancer	3.65e-05	0.0001	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—hematologic cancer	3.65e-05	0.0001	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.65e-05	0.0001	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—hematologic cancer	3.62e-05	9.93e-05	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—hematologic cancer	3.57e-05	9.78e-05	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—hematologic cancer	3.56e-05	9.76e-05	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—hematologic cancer	3.54e-05	9.7e-05	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—hematologic cancer	3.52e-05	9.67e-05	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.52e-05	0.00028	CbGpPWpGaD
Dantrolene—Vomiting—Prednisone—hematologic cancer	3.52e-05	9.65e-05	CcSEcCtD
Dantrolene—Rash—Prednisone—hematologic cancer	3.49e-05	9.57e-05	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—hematologic cancer	3.48e-05	9.56e-05	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—hematologic cancer	3.48e-05	9.55e-05	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.47e-05	0.000276	CbGpPWpGaD
Dantrolene—Headache—Prednisone—hematologic cancer	3.47e-05	9.51e-05	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—hematologic cancer	3.45e-05	9.47e-05	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—hematologic cancer	3.44e-05	9.43e-05	CcSEcCtD
Dantrolene—Pain—Doxorubicin—hematologic cancer	3.42e-05	9.39e-05	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—hematologic cancer	3.42e-05	9.39e-05	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—hematologic cancer	3.42e-05	9.38e-05	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—hematologic cancer	3.42e-05	9.38e-05	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—hematologic cancer	3.41e-05	9.34e-05	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—hematologic cancer	3.32e-05	9.1e-05	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—hematologic cancer	3.3e-05	9.05e-05	CcSEcCtD
Dantrolene—Nausea—Prednisone—hematologic cancer	3.29e-05	9.01e-05	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.27e-05	8.98e-05	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—hematologic cancer	3.27e-05	8.97e-05	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.23e-05	0.000257	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.19e-05	0.000254	CbGpPWpGaD
Dantrolene—Hypersensitivity—Epirubicin—hematologic cancer	3.19e-05	8.74e-05	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—hematologic cancer	3.18e-05	8.72e-05	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—hematologic cancer	3.16e-05	8.68e-05	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—hematologic cancer	3.16e-05	8.68e-05	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—hematologic cancer	3.16e-05	8.68e-05	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—hematologic cancer	3.1e-05	8.52e-05	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—hematologic cancer	3.06e-05	8.4e-05	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—hematologic cancer	3.06e-05	8.39e-05	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—hematologic cancer	2.96e-05	8.12e-05	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—hematologic cancer	2.95e-05	8.09e-05	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—hematologic cancer	2.94e-05	8.06e-05	CcSEcCtD
Dantrolene—Rash—Methotrexate—hematologic cancer	2.92e-05	8e-05	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—hematologic cancer	2.91e-05	7.99e-05	CcSEcCtD
Dantrolene—Headache—Methotrexate—hematologic cancer	2.9e-05	7.94e-05	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—hematologic cancer	2.87e-05	7.88e-05	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—hematologic cancer	2.86e-05	7.85e-05	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—hematologic cancer	2.83e-05	7.77e-05	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—hematologic cancer	2.75e-05	7.55e-05	CcSEcCtD
Dantrolene—Nausea—Methotrexate—hematologic cancer	2.75e-05	7.53e-05	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—hematologic cancer	2.74e-05	7.51e-05	CcSEcCtD
Dantrolene—Rash—Epirubicin—hematologic cancer	2.73e-05	7.48e-05	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—hematologic cancer	2.73e-05	7.48e-05	CcSEcCtD
Dantrolene—Headache—Epirubicin—hematologic cancer	2.71e-05	7.44e-05	CcSEcCtD
Dantrolene—CYP3A4—Metabolism—GMPS—hematologic cancer	2.7e-05	0.000215	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PHYH—hematologic cancer	2.7e-05	0.000215	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FTCD—hematologic cancer	2.7e-05	0.000215	CbGpPWpGaD
Dantrolene—Dizziness—Doxorubicin—hematologic cancer	2.65e-05	7.26e-05	CcSEcCtD
Dantrolene—Nausea—Epirubicin—hematologic cancer	2.57e-05	7.05e-05	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—hematologic cancer	2.55e-05	6.98e-05	CcSEcCtD
Dantrolene—Rash—Doxorubicin—hematologic cancer	2.52e-05	6.92e-05	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—hematologic cancer	2.52e-05	6.92e-05	CcSEcCtD
Dantrolene—Headache—Doxorubicin—hematologic cancer	2.51e-05	6.88e-05	CcSEcCtD
Dantrolene—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.47e-05	0.000196	CbGpPWpGaD
Dantrolene—Nausea—Doxorubicin—hematologic cancer	2.38e-05	6.52e-05	CcSEcCtD
Dantrolene—CYP3A4—Metabolism—DCK—hematologic cancer	2.15e-05	0.000172	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ASNS—hematologic cancer	2.15e-05	0.000172	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.15e-05	0.000172	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HDC—hematologic cancer	2.04e-05	0.000163	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CDA—hematologic cancer	1.87e-05	0.000149	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PC—hematologic cancer	1.8e-05	0.000143	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.74e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GBA—hematologic cancer	1.74e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTAP—hematologic cancer	1.59e-05	0.000126	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FHL2—hematologic cancer	1.42e-05	0.000113	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGRN—hematologic cancer	1.39e-05	0.000111	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—IDH2—hematologic cancer	1.32e-05	0.000105	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMMR—hematologic cancer	1.32e-05	0.000105	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.24e-05	9.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA9—hematologic cancer	1.2e-05	9.58e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACP5—hematologic cancer	1.2e-05	9.58e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.19e-05	9.46e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—IDH1—hematologic cancer	1.13e-05	9.01e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TXN—hematologic cancer	1.12e-05	8.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.12e-05	8.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.12e-05	8.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.1e-05	8.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.05e-05	8.38e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.02e-05	8.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.02e-05	8.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.98e-06	7.94e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NUP98—hematologic cancer	9.66e-06	7.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADCY7—hematologic cancer	9.38e-06	7.47e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOA3—hematologic cancer	9.38e-06	7.47e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NUP214—hematologic cancer	9.31e-06	7.41e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTR—hematologic cancer	9.12e-06	7.26e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCG2—hematologic cancer	9.12e-06	7.26e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO2—hematologic cancer	8.95e-06	7.12e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—hematologic cancer	8.68e-06	6.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SDC1—hematologic cancer	8.48e-06	6.75e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NQO1—hematologic cancer	7.21e-06	5.74e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD44—hematologic cancer	7.21e-06	5.74e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYCS—hematologic cancer	6.82e-06	5.43e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.78e-06	5.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.02e-06	4.79e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.69e-06	4.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.53e-06	4.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.53e-06	4.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.89e-06	3.89e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.1e-06	3.27e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.81e-06	3.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.61e-06	2.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—hematologic cancer	3.56e-06	2.84e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.41e-06	2.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.15e-06	2.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTEN—hematologic cancer	2.72e-06	2.16e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—EP300—hematologic cancer	2.59e-06	2.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—hematologic cancer	1.57e-06	1.25e-05	CbGpPWpGaD
